[HTML][HTML] Irisin as a novel biomarker of subclinical atherosclerosis, cardiovascular risk and severe disease in axial spondyloarthritis

…, C Fernández-Carballido, MP Martínez-Vidal… - Frontiers in …, 2022 - frontiersin.org
Introduction Patients with axial spondyloarthritis (axSpA) have a high disease burden mainly
due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads …

Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients

…, C Fernández-Carballido, MP Martínez-Vidal… - Seminars in Arthritis and …, 2021 - Elsevier
Objectives To compare the atherosclerosis disease burden between ankylosing spondylitis (AS)
and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a model that …

[HTML][HTML] Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study

…, C Fernández-Carballido, MP Martínez-Vidal… - Arthritis Research & …, 2021 - Springer
Background Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV)
disease and inflammation in chronic inflammatory conditions different from axial …

[HTML][HTML] Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis

…, C Fernández-Carballido, MP Martínez-Vidal… - Scientific Reports, 2020 - nature.com
Cardiovascular (CV) disease is the main cause of mortality in axial spondyloarthritis (axSpA).
CV risk is enhanced by dysregulation of adipokines. Low omentin levels were associated …

Is the SCORE chart underestimating the real cardiovascular (CV) risk of patients with psoriatic arthritis? Prevalence of subclinical CV disease detected by carotid …

MP Martínez-Vidal, C Fernández-Carballido - Joint Bone Spine, 2018 - Elsevier
Objectives To analyse the cardiovascular risk according to the SCORE chart in a series of
patients with psoriatic arthritis, and to study the presence of subclinical cardiovascular disease …

Spanish registry of recent-onset psoriatic arthritis (REAPSER study): aims and methodology

…, C Fernández-Carballido, MP Martínez-Vidal… - … Clínica (English Edition), 2019 - Elsevier
Aims To describe the methodology of REAPSER (Spanish Registry of Recent-onset Psoriatic
Arthritis), its strengths and limitations. The aim of this study is to identify prognostic factors …

Use of benzodiazepines and antidepressants in patients who attend a Rheumatology clinic

A Álvarez-Cienfuegos, MP Martínez-Vidal… - Revista Colombiana de …, 2021 - Elsevier
Introduction During the last decades, benzodiazepines (BZD) and antidepressants (ADP)
have been among the most prescribed therapies in all developed countries. They have side …

Role of carotid ultrasound and systematic coronary risk evaluation charts for the cardiovascular risk stratification of patients with psoriatic arthritis

MP Martínez-Vidal, M Andrés, V Jovaní… - The Journal of …, 2020 - jrheum.org
Objective. The assessment of the cardiovascular (CV) risk is recommended in patients with
chronic inflammatory rheumatic diseases. The objectives of this study were to assess the CV …

Cribado del virus de papiloma humano: evaluación de grado de vigilancia en artritis reumatoide, artritis psoriásica y lupus eritematoso sistémico

…, RL Poza, M Andrés, MP Martínez-Vidal - Reumatología …, 2021 - Elsevier
Introducción y objetivos La inmunosupresión es un factor de riesgo conocido para el cáncer
de cérvix uterino. Las mujeres con enfermedades reumáticas están inmunosuprimidas por …

Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus

…, RL Poza, M Andrés, MP Martínez-Vidal - … Clínica (English Edition), 2021 - Elsevier
Background and objectives Immunosuppression is a known risk factor for cervical cancer.
Women with rheumatic conditions are immunosuppressed due to the disease and the …